Experimental cell therapy aims to stop deadly transplant complication
Disease control
Terminated
This early-stage study tested whether specially prepared stem cells could safely prevent graft-versus-host disease (GVHD) in patients receiving bone marrow transplants for blood cancers. GVHD is a serious and common complication where the donor's immune cells attack the patient's…
Phase: PHASE1 • Sponsor: Edwin Horwitz • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC